Quick View
Loading...
Dragon Pharma
Estimated Delivery: 12-26 Days (International), 3-6 Days (United States)
Return within 45 Days of purchase. Duties & taxes are non-refundable.
Buy Ipamorelin and Tesamorelin 10 mg by Dragon Pharma at XSteroids. This blend pairs the only truly approved drug in the growth hormone group with the most selective of the research peptides. Dragon Pharma supplies it as a 10 mg lyophilized vial. This guide covers what each component is, tesamorelin dosage questions, the approved indication and what the combination does not have data for.
Tesamorelin is a prescription medicine for a specific indication; the blend itself is not an approved product, so the information below is educational only.
It combines two peptides that reach the GH axis from different directions. Tesamorelin is a synthetic form of growth hormone-releasing hormone and one of the few compounds in this catalog that is a real medicine. Ipamorelin is a pentapeptide and a selective agonist of the ghrelin receptor. The vial contains both, and the split between them is set by the manufacturer.
Worth being precise here: what is approved is Egrifta, a specific tesamorelin product with a defined dose, formulation and indication. A research blend containing tesamorelin plus another peptide is not that product.
Tesamorelin is a synthetic peptide made of all 44 amino acids of human GHRH, with a trans-3-hexenoic acid group added at the N-terminus that protects it from enzymatic cleavage. It was approved in 2010 for HIV-associated lipodystrophy and is produced by Theratechnologies. It carries an ATC code, H01AC06, and is prescription-only.
It stimulates the synthesis and release of endogenous GH, which raises IGF-1, and the resulting signalling regulates body composition through both anabolic and lipolytic mechanisms - the basis for its use in reducing excess abdominal fat. Its bioavailability is 4% or less and its elimination half-life is only 26 to 38 minutes, so it is given by subcutaneous injection and does not stay in circulation long.
In medicine, tesamorelin is dosed daily by subcutaneous injection as a fixed prescription product. In a research blend the calculation changes: the vial holds 10 mg of two peptides, so the reconstitution ratio decides how much of each component a given volume delivers. There is no clinical dose for the combination.
Mix the lyophilized powder with bacteriostatic water, aiming the stream at the vial wall rather than the powder, then swirl gently instead of shaking. Label the vial with the date, keep it refrigerated, and treat a punctured multi-dose vial as usable for 28 days after the first puncture.
The documented adverse effects are injection site erythema and itching, peripheral edema and diarrhea; with frequent use, joint, arm and leg pain can occur as body fat is depleted. Tesamorelin is also contraindicated when the hypothalamic-pituitary axis is disrupted - pituitary tumours, prior head irradiation or hypopituitarism - and in pregnancy. Those are real clinical constraints attached to the approved drug, and they do not disappear because the peptide arrives in a research vial.
The two components illustrate the whole category. Tesamorelin is a GHRH analogue - like CJC-1295 DAC and Sermorelin, it acts on the GHRH receptor - but unlike them it is a marketed medicine with a defined indication. Ipamorelin, like GHRP-2 and GHRP-6, acts on the ghrelin receptor, and it is the one that avoids ACTH and cortisol stimulation. Pairing them means hitting both receptors at once, which is the same logic as the CJC-1295 and Ipamorelin blend.
Store the lyophilized vial in a cool, dry place away from direct light before reconstitution. After mixing with bacteriostatic water, keep the solution refrigerated and use it within the recommended period for peptide solutions. Keep vials out of the reach of children.
At XSteroids you buy the Dragon Pharma Ipamorelin and Tesamorelin blend directly from the brand catalog, with secure checkout, US domestic shipping in 3 to 6 days and international delivery in 12 to 26 days. Browse the full range on the Dragon Pharma brand page to complete your research protocol.
It combines tesamorelin, a synthetic GHRH analogue and an approved prescription medicine, with ipamorelin, a selective ghrelin receptor agonist. Dragon Pharma supplies it as a 10 mg lyophilized vial for laboratory research use only rather than as an approved medicine. The vial is a research product.
The approved product is Egrifta, given for HIV-associated lipodystrophy to reduce excess abdominal fat. It was approved in 2010 and is produced by Theratechnologies. That indication belongs to the prescription medicine, not to a research blend sold for laboratory work.
Medically it is injected subcutaneously once daily as a fixed prescription product. In this blend the 10 mg vial contains two peptides, so the reconstitution ratio decides the amount per injection, and there is no clinical dose for the combination itself.
It stimulates the synthesis and release of endogenous growth hormone, which raises IGF-1 and regulates body composition through anabolic and lipolytic mechanisms. Its half-life is short, only 26 to 38 minutes, and bioavailability is 4% or less, which is why it is injected rather than taken orally.
Injection site redness and itching, peripheral edema and diarrhea are documented, and frequent use can bring joint, arm and leg pain as fat mass drops. It is also contraindicated in pituitary axis disruption and in pregnancy, so it is not a casual option.
Tesamorelin acts on the GHRH receptor and is a marketed medicine; ipamorelin acts on the ghrelin receptor and is an unapproved research peptide that does not stimulate ACTH or cortisol. The blend covers both receptors at once, which is the point of pairing them.
You can buy the Ipamorelin and Tesamorelin 10 mg vial by Dragon Pharma online at XSteroids. The store offers secure checkout, US domestic shipping in 3 to 6 days and international delivery in 12 to 26 days. Add the vial to your cart on this page.
Loading...
Your cart is currently empty. Let us assist you in finding the right product